FDA medical device news and insights
News articles that explain new FDA clearances and approvals, guidance, AI devices and premarket pathways in plain terms — for product development and regulatory teams.
The 3 newest articles are free to read in full. Members can read every article.
日本語の記事- FDA Publishes a PCCP Page With a List of 240 Devices; 20 Records Not on the List Have PCCP Review Language in Their LettersOn October 20, 2026, FDA published a page on predetermined change control plans (PCCPs) with a list of 240 devices authorized with a PCCP, along with hypothetical case examples for AI devices. Fifty-six of the 240 are PMA supplements; of the 46 whose approval statements say what the PCCP covers, about four in five plan manufacturing, supplier or facility changes. One hypothetical example is an AI that goes from retraining to deployment without human decision-making. Checked against RA Craft Database records, 20 510(k)s are absent from the list and read No in the PCCP field on FDA's record pages, yet their clearance letters say a PCCP was reviewed and cleared. For 16, other text confirms the plan's title or content; for four, only the letter's standard paragraph does.
- CDRH's FY 2027 Guidance Plan: PCCP Stays on the A-List and AI Software Moves Up From the B-ListFDA's Center for Devices and Radiological Health (CDRH) has published its guidance plan for fiscal year 2027 (October 2026 to September 2027). The A-list, which prioritizes publication during the year, has eight items. Finalizing the PCCP guidance for medical devices in general is on it for the second year running, and finalizing the AI-enabled device software functions guidance has moved up from the B-list. A planned draft on generative AI-enabled conversational devices for mental disorders is new. We set the FY 2027 items against last year's plan and list the items that were on last year's plan but are not on this one. Comments on the plan are open until November 30.